Alkeon Capital Management Portfolio holdings
AUM
$20.6B
This Quarter Return
+0.14%
1 Year Return
+8.97%
3 Year Return
+43.14%
5 Year Return
+49.88%
10 Year Return
+256.15%
AUM
$26.3B
AUM Growth
+$26.3B
(-0.51%)
Cap. Flow
+$685M
Cap. Flow
% of AUM
2.6%
Top 10 Holdings %
Top 10 Hldgs %
27.33%
Holding
181
New
24
Increased
67
Reduced
30
Closed
15
Top Buys
| 1 |
Expedia Group
EXPE
|
$382M |
| 2 |
Uber
UBER
|
$357M |
| 3 |
Lyft
LYFT
|
$321M |
| 4 |
Netflix
NFLX
|
$287M |
| 5 |
Burlington
BURL
|
$255M |
Top Sells
| 1 |
Bilibili
BILI
|
$301M |
| 2 |
Alibaba
BABA
|
$271M |
| 3 |
Pinterest
PINS
|
$243M |
| 4 |
Sea Limited
SE
|
$228M |
| 5 |
Salesforce
CRM
|
$212M |
Sector Composition
| 1 | Technology | 46.12% |
| 2 | Consumer Discretionary | 17.62% |
| 3 | Communication Services | 10.44% |
| 4 | Financials | 7.47% |
| 5 | Healthcare | 5.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MORF
101
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $24.8M | 0.04% |
392,000
+242,000
| +161% | +$15.3M |
|
102
Oric Pharmaceuticals
ORIC
$1.03B
| $24.5M | 0.04% |
998,061
+100,000
| +11% | +$2.45M |
|
103
Zoom
ZM
$25B
| $24.4M | 0.04% |
76,000
+16,000
| +27% | +$5.14M |
|
|
CERE
104
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $24M | 0.04% |
1,750,000
| – | – |
|
105
Applied Therapeutics
APLT
$73.7M
| $19.5M | 0.03% |
1,041,334
+301,781
| +41% | +$5.66M |
|
106
Avidity Biosciences
RNA
$6.12B
| $19.1M | 0.03% |
875,000
| – | – |
|
107
4D Molecular Therapeutics
FDMT
$302M
| $17.5M | 0.03% |
402,926
+1,041
| +0.3% | +$45.2K |
|
108
Datadog
DDOG
$46.2B
| $17.1M | 0.03% |
204,730
-10,270
| -5% | -$856K |
|
109
Stem
STEM
$121M
| $14.6M | 0.02% |
+550,000
| New | +$14.6M |
|
110
Elastic
ESTC
$9.17B
| $13.9M | 0.02% |
125,000
+45,000
| +56% | +$5M |
|
111
NetEase
NTES
$85.4B
| $10.9M | 0.02% |
105,095
-957,040
| -90% | -$98.8M |
|
112
Zillow
ZG
$19.6B
| $10.5M | 0.02% |
+80,000
| New | +$10.5M |
|
|
YSG
113
Yatsen Holding
YSG
$873M
| $10.5M | 0.02% |
847,672
-705,854
| -45% | -$8.72M |
|
|
ATC
114
DELISTED
Atotech Limited
ATC
| $6.6M | 0.01% |
+325,900
| New | +$6.6M |
|
|
MREO
115
Mereo BioPharma
MREO
$275M
| $6.52M | 0.01% |
1,935,600
| – | – |
|
116
Restaurant Brands International
QSR
$20.5B
| $6.5M | 0.01% |
100,000
-1,108,776
| -92% | -$72.1M |
|
117
Neurogene
NGNE
$284M
| $6.16M | 0.01% |
500,000
| – | – |
|
118
Sony
SONY
$162B
| $5.83M | 0.01% |
+55,000
| New | +$5.83M |
|
119
CrowdStrike
CRWD
$104B
| $5.48M | 0.01% |
30,000
-100,000
| -77% | -$18.3M |
|
120
Olo Inc
OLO
$1.74B
| $5.28M | 0.01% |
+200,000
| New | +$5.28M |
|
121
Take-Two Interactive
TTWO
$44.1B
| $2.81M | ﹤0.01% |
15,916
| – | – |
|
122
Unity
U
$16.5B
| $2.71M | ﹤0.01% |
27,000
| – | – |
|
123
Varonis Systems
VRNS
$6.21B
| $2.31M | ﹤0.01% |
+45,000
| New | +$2.31M |
|
124
Sana Biotechnology
SANA
$759M
| $2.01M | ﹤0.01% |
+60,000
| New | +$2.01M |
|
125
Relmada Therapeutics
RLMD
$48.8M
| $1.76M | ﹤0.01% |
50,000
| – | – |
|